Radix Astragali lowers kidney oxidative stress in diabetic rats treated with insulin

Endocrine

Volumn 42, Issue 3, 2012, Pages 592-598

  Gao, Y ^a   Zhang, R R ^a   Li, J H ^b   Ren, M ^b   Ren, Z X ^b   Shi, J H ^b   Pan, Q Z ^b   Ren, S P ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Kidney damage; NF B; Oxidative stress; Radix Astragali

Indexed keywords

ASTRAGALUS EXTRACT; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; MALONALDEHYDE; PROTEIN KINASE C ALPHA; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTRAGALUS PLANT; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFICACY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GLUCOSE BLOOD LEVEL; KIDNEY MASS; MALE; NONHUMAN; OXIDATIVE STRESS; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; RISK REDUCTION; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; WESTERN BLOTTING; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ASTRAGALUS PLANT; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLUTATHIONE PEROXIDASE; HYPOGLYCEMIC AGENTS; INSULIN; INTERLEUKIN-6; KIDNEY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878252270     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9670-7     Document Type: Article

References (25)

1. R.A. Kowluru, P.S. Chan, Oxidative stress and diabetic retinopathy. Exp. Diabetes. Res. (2007). doi: 10.1155/2007/43603
2. J.M. Forbes, M.T. Coughlan, M.E. Cooper, Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57(6), 1446-1454 (2008)
3. G.L. Bakris, Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin. Proc. 86(5), 444-456 (2011)
4. C. Maric, J.E. Hall, Obesity, metabolic syndrome and diabetic nephropathy. Contrib. Nephrol. 170, 28-35 (2011)
5. P.K. Mishra, S.R. Singh, I.G. Joshua, S.C. Tyagi, Stem cells as a therapeutic target for diabetes. Front. Biosci. 15, 461-477 (2011)
6. A. Ceriello, R. Testa, Antioxidant anti-Inflammatory treatment in type 2 diabetes. Diabetes Care 32(Suppl 2), S232-S236 (2009)
7. I. Seghrouchni, J. Drai, E. Bannier, J. Rivie're, P. Calmard, I. Garcia et al., Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin. Chim. Acta 321(1-2), 89-96 (2002)
8. J.L. Rains, S.K. Jain, Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 50(5), 567-575 (2011)
9. Y. Feng, L. Feng, Protective effect of Astragalus membranaceus on diabetic nephropathy in rats. J. Prac. Med. 22(21), 2457-2459 (2006)
10. J.J. Liu, W.Y. La, H.F. Wang, C.Y. Bai, J. Liang, Y. Ma et al., Effects of astragalus compound particles on glucose and lipid metabolism and pancreatic function of diabetic rats. Li Shi Zhen Medicine Materia Medica Research. 22(8), 1923-1926 (2011)
11. H. Cheng, R.H. Jia, H.Y. Liu, Effects of astragalus on renal injury of diabetic rats. J. Chinese Phys. 8(10), 1349-1351 (2006)
12. X.X. Zhang, S. Cao, M.S. Miao, Astragalus in diabetes and its complications of application. China J. Chinese Med. 11, 1323-1325 (2011)
13. H. You, Y. Lu, D. Gui, A. Peng, J. Chen, Y. Gu, Aqueous extract of Astragali Radix ameliorates proteinuria in adriamycin nephropathy rats through inhibition of oxidative stress and endothelial nitric oxide synthase. J. Ethnopharmacol. 134(1), 176-182 (2011)
14. D.G. Hafeman, R.A. Sunde, W.G. Hoekstra, Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104(5), 580-587 (1974)
15. R.C. Stanton, Oxidative stress and diabetic kidney disease. Curr. Diab. Rep. 11(4), 330-336 (2011)
16. F.K. Ahmad, Z. He, G.L. King, Molecular targets of diabetic cardiovascular complications. Curr. Drug Targets 6(4), 487-494 (2005)
17. M. Brownlee, Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865), 813-820 (2001)
18. S.P. Bagby, Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity. Kidney Int. 71(9), 912-923 (2007)
19. H. Fujita, H. Fujishima, S. Chida, K. Takahashi, Z. Qi, Y. Kanetsuna et al., Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J. Am. Soc. Nephrol. 20(6), 1303-1313 (2009)
20. M.E. Shams, M.M. AL-Gayyar, E.A. Barakat, Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines. Sci. Pharm 79(3), 623-634 (2011)
21. K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola et al., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106(16), 2067-2072 (2002)
22. D.K. Singh, P. Winocour, K. Farrington, Oxidative stress in early diabetic nephropathy: fueling the fire. Nat. Rev. Endocrinol. 7, 176-184 (2011)
23. C. Guijarro, J. Egido, Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int. 59(2), 415-424 (2001)
24. M. Romagnoli, M.C. Gomez-Cabrera, M.G. Perrelli, F. Biasi, F.V. Pallardó, J. Sastre et al., Xanthine oxidase-induced oxidative stress causes activation of NF-κB and inflammation in the liver of type I diabetic rats. Free Radic. Biol. Med. 49(2), 171-177 (2010)
25. J.Q. Zhang, X.S. Xie, C. Li, P. Fu, Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J. Ethnopharmacol. 126, 189-196 (2009)